Welcome to our dedicated page for KeyCorp news (Ticker: KEY), a resource for investors and traders seeking the latest updates and insights on KeyCorp stock.
KeyCorp reports developments across its KeyBank banking franchise, KeyBanc Capital Markets, and wealth-management operations. Company news commonly covers deposit, lending, cash management, and investment services for individuals and businesses in its multi-state banking footprint, along with commercial banking coverage for middle-market companies.
Recurring updates include quarterly earnings, net interest income, fee-based businesses such as investment banking, commercial payments, and wealth management, and regional expansion of middle-market teams. News also covers Key Private Bank, customer financial surveys, community partnerships, and capital-markets services including M&A advice, public and private debt and equity, syndications, and derivatives.
KeyCorp (NYSE: KEY) announced board changes effective at its 2026 Annual Meeting. The Board will nominate Antonio DeSpirito and Christopher L. Henson for election as directors, adding expertise in public markets, capital allocation, banking operations and risk management. Todd Vasos was appointed Lead Independent Director, succeeding Alexander M. "Sandy" Cutler, who will remain an independent director. Carlton Highsmith and Ruth Ann Gillis will retire at the Annual Meeting. The Board will remain at 14 directors. Key reported total assets of approximately $184 billion at December 31, 2025.
KeyCorp (NYSE: KEY) reported Q4 2025 net income $474 million, or $0.43 per diluted share, and adjusted net income $458 million, or $0.41 per diluted share. Q4 revenue $2.00 billion; full-year revenue a record $7.5 billion, up 16% year-over-year (adjusted). Taxable-equivalent net interest income was $1.22 billion and net interest margin was 2.82%. Pre-provision net revenue rose $46 million sequentially and full-year pre-provision net revenue increased 44% (adjusted). Assets under management reached a record $70 billion. Common Equity Tier 1 ratio was estimated at 11.7%.
Rigel Pharmaceuticals (Nasdaq: RIGL) announced the first patient enrollment in a Phase 1b/2 trial at MD Anderson testing oral or IV decitabine and venetoclax combined with REZLIDHIA (olutasidenib) for mIDH1 acute myeloid leukemia (AML) on Jan 15, 2026.
The Phase 1b portion will assess safety/tolerability and recommended Phase 2 dose; the Phase 2 will enroll 60 patients (30 newly diagnosed, 30 relapsed/refractory) to evaluate complete remission rate. REZLIDHIA is FDA‑indicated for relapsed/refractory mIDH1 AML. The release includes safety data: differentiation syndrome and hepatotoxicity incidence and management guidance.
KeyCorp (NYSE: KEY) said it is lowering its prime lending rate to 6.75% from 7.00%, effective Dec. 11, 2025.
The announcement notes KeyBank is headquartered in Cleveland and reported approximately $187 billion in assets as of Sept. 30, 2025. Key provides deposit, lending, cash management and investment services in 15 states through about 1,000 branches and 1,200 ATMs, and operates corporate and investment banking under the KeyBanc Capital Markets name.
KeyCorp is marking its 200th anniversary in 2025.
HoldCo Asset Management (manager of approximately $2.6 billion regulatory assets) released a presentation to the Independent Directors of KeyCorp (NYSE: KEY) on December 5, 2025 titled "Read My Lips: No New Acquisitions."
HoldCo disclosed it owns common stock and debt of KeyCorp or its subsidiaries and stated it has an economic interest in the price of those securities. The presentation is available online at HoldCo's website.
KeyCorp (NYSE: KEY) announced that Chairman and CEO Chris Gorman will speak at the Goldman Sachs Financial Services Conference on Tuesday, December 9, 2025 at 8:40 a.m. ET in New York City.
The company said it will review performance, strategy, and outlook; the live audio webcast will be available on the day of the conference at www.key.com/ir, with replays available under Events & Presentations.
Key facts: Key marks its 200th year in 2025, reported approximately $187 billion in assets at September 30, 2025, and operates about 1,000 branches and 1,200 ATMs across 15 states.
KeyCorp (NYSE:KEY) announced that KeyBank National Association will redeem all outstanding 4.700% Fixed Rate Senior Bank Notes due January 26, 2026 (CUSIP 49327M3G7) on December 29, 2025. The redemption price is 100% of outstanding principal plus accrued and unpaid interest to, but excluding, the redemption date.
KeyCorp reported total assets of approximately $187 billion as of September 30, 2025. The company provides banking and capital markets services through about 1,000 branches and 1,200 ATMs across 15 states.
KeyCorp (NYSE: KEY) declared quarterly cash dividends for Q4 2025. The corporation will pay a $0.205 per common share dividend on Dec 15, 2025 to holders of record as of Dec 2, 2025.
KeyCorp also declared dividends on its preferred series with Dec 15, 2025 payment dates and Dec 1, 2025 record dates: Series D $312.50 per share (or $12.50 per depositary share), Series E $15.3125 per share (or $0.382813 per depositary share, NYSE: KEY.I), Series F $14.1250 (or $0.353125, NYSE: KEY.J), Series G $14.0625 (or $0.351563, NYSE: KEY.K), and Series H $15.50 (or $0.3875, NYSE: KEY.L).
KeyBank (NYSE: KEY) released a Middle Market Snapshot from October 2025 surveying 392 executives of businesses with $25M–$1B revenue about the One Big Beautiful Bill Act (OBBBA).
Key findings: 60% report familiarity with OBBBA, 86% expect a moderate-or-greater U.S. economic impact in 12 months, 60% expect meaningful business benefits within two years, and 89% foresee at least one significant long-term impact. Top planned actions within 12 months include technology upgrades (68%), domestic R&D (65%), and supply-chain changes (63%).
KeyCorp (NYSE: KEY) highlighted findings from the 16th annual Private Company SaaS Survey (Nov 13, 2025) by KeyBanc Capital Markets and Sapphire Ventures showing renewed growth and continued focus on profitability among private SaaS firms.
Key metrics: ARR growth expected to accelerate from 15% (2024) to 20% (2025); gross retention down to 86% in 2023 but approaching 90%; net retention remains above 100%. AI adoption is broad: >50% plan to increase AI spend by >21% and 67% are already monetizing AI, mostly via subscription models. EBITDA margins are improving and are expected to breach profitability in 2026.